Loading...
CELLULAR AND MOLECULAR IMMUNOLOGY OF LUNG CANCER: THERAPEUTIC IMPLICATIONS
Though incidence is declining, the prognosis of lung cancer remains poor. This is likely due to lack of early detection and only recent developments in selective cancer therapies. Key immune cells involved in the pathogenesis of lung cancer include CD4(+) T-lymphocytes, macrophages, dendritic cells,...
Saved in:
Published in: | Expert Rev Clin Immunol |
---|---|
Main Authors: | , , |
Format: | Artigo |
Language: | Inglês |
Published: |
2014
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4596236/ https://ncbi.nlm.nih.gov/pubmed/25351434 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/1744666X.2014.975692 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|